1994
DOI: 10.1038/clpt.1994.14
|View full text |Cite
|
Sign up to set email alerts
|

Nicotine metabolism in cigarette smokers and nonsmokers

Abstract: Clinical Pharmacology and Therapeutics (1994) 55, 84–85; doi:

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…For example, the tobacco alkaloid and active nicotine metabolite nornicotine serves as a both a psychostimulant and positive reinforcer in rats (Bardo et al, 1999; Green et al, 2001). Nornicotine has an 8X longer plasma half-life compared to nicotine in both human smokers and non-smokers (Kyerematen et al, 1994), and is known to accumulate in rat brain with repeated intermittent peripheral injections (Ghosheh et al, 1999). Thus, even the short-access schedule used here would be expected to provide an extended post-session period of nicotinic receptor activation, which is a critical component for the addictive process.…”
Section: Discussionmentioning
confidence: 99%
“…For example, the tobacco alkaloid and active nicotine metabolite nornicotine serves as a both a psychostimulant and positive reinforcer in rats (Bardo et al, 1999; Green et al, 2001). Nornicotine has an 8X longer plasma half-life compared to nicotine in both human smokers and non-smokers (Kyerematen et al, 1994), and is known to accumulate in rat brain with repeated intermittent peripheral injections (Ghosheh et al, 1999). Thus, even the short-access schedule used here would be expected to provide an extended post-session period of nicotinic receptor activation, which is a critical component for the addictive process.…”
Section: Discussionmentioning
confidence: 99%